IS7422A - Efni með viðloðunareiginleika - Google Patents

Efni með viðloðunareiginleika

Info

Publication number
IS7422A
IS7422A IS7422A IS7422A IS7422A IS 7422 A IS7422 A IS 7422A IS 7422 A IS7422 A IS 7422A IS 7422 A IS7422 A IS 7422A IS 7422 A IS7422 A IS 7422A
Authority
IS
Iceland
Prior art keywords
adhesive properties
adhesive
properties
Prior art date
Application number
IS7422A
Other languages
English (en)
Inventor
Gizurarson Sveinbjörn
Original Assignee
Lyfjathroun Hf.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lyfjathroun Hf. filed Critical Lyfjathroun Hf.
Publication of IS7422A publication Critical patent/IS7422A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IS7422A 2002-02-25 2004-08-24 Efni með viðloðunareiginleika IS7422A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IS6283 2002-02-25
IS6453 2002-07-03
PCT/IS2003/000009 WO2003070273A1 (en) 2002-02-25 2003-02-24 A bioadhesive agent

Publications (1)

Publication Number Publication Date
IS7422A true IS7422A (is) 2004-08-24

Family

ID=36763295

Family Applications (2)

Application Number Title Priority Date Filing Date
IS7421A IS7421A (is) 2002-02-25 2004-08-24 Frásogshvati
IS7422A IS7422A (is) 2002-02-25 2004-08-24 Efni með viðloðunareiginleika

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IS7421A IS7421A (is) 2002-02-25 2004-08-24 Frásogshvati

Country Status (11)

Country Link
US (2) US20050106122A1 (is)
EP (2) EP1480673A1 (is)
JP (1) JP2005519075A (is)
KR (1) KR20040095232A (is)
CN (1) CN1642576A (is)
AU (2) AU2003215885B2 (is)
BR (1) BR0307913A (is)
CA (1) CA2477321A1 (is)
IS (2) IS7421A (is)
NZ (1) NZ534738A (is)
WO (2) WO2003070280A2 (is)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ534738A (en) * 2002-02-25 2007-01-26 Lyfjathroun Hf Absorption enhancing agent
CA2569964A1 (en) * 2004-06-10 2005-12-29 Duramed Pharmaceuticals, Inc. Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same
TW200824693A (en) 2006-08-28 2008-06-16 Jazz Pharmaceuticals Inc Pharmaceutical compositions of clonazepam and methods of use thereof
BRPI0622061B8 (pt) * 2006-10-23 2021-05-25 Ecolab Inc composição viricida, uso e produto compreendendo a mesma
US8431692B2 (en) * 2008-06-06 2013-04-30 Quark Pharmaceuticals, Inc. Compositions and methods for treatment of ear disorders
BRPI0918253A2 (pt) 2008-09-12 2015-12-15 Critical Pharmaceuticals Ltd aperfeicoamento na absorcao de agentes terapeuticos atraves das membranas mucosas ou da pele
EP2512231B1 (en) 2009-12-16 2016-12-07 Ecolab Inc. Composition in form of a gel for the virucidal disinfection of mammalian skin
AU2017283276B2 (en) 2016-06-20 2023-02-16 Capretto Ehf. Thermostable formulation of biologically active substances
CA3142842A1 (en) * 2019-06-07 2020-12-10 Paxmedica, Inc. Compositions and methods for treating central nervous system disorders
US20230301903A1 (en) * 2022-03-25 2023-09-28 Neurelis, Inc. Intranasal olanzapine formulations and methods of their use

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3225706C2 (de) * 1982-07-09 1984-04-26 A. Nattermann & Cie GmbH, 5000 Köln Flüssige Wirkstofformulierungen in Form von Konzentraten für Mikroemulsionen
US5019395A (en) * 1988-03-08 1991-05-28 Warner-Lambert Company Compositions with enhanced penetration
ATE94404T1 (de) * 1988-07-21 1993-10-15 Hoffmann La Roche Insulinzubereitung.
US5190748A (en) * 1988-11-22 1993-03-02 Hoffmann-La Roche Inc. Absorption enhancement of antibiotics
DE69229779T2 (de) * 1991-04-19 1999-12-23 Lds Technologies, Inc. Konvertierbare mikroemulsionsverbindungen
CA2083553A1 (en) * 1991-11-25 1993-05-26 Kuniharu Seki Immunogen composition
US5314685A (en) * 1992-05-11 1994-05-24 Agouron Pharmaceuticals, Inc. Anhydrous formulations for administering lipophilic agents
IT1255895B (it) * 1992-10-20 1995-11-17 Laura Chiodini Composizioni farmaceutiche contenenti una calcitonina
DK17093D0 (da) * 1993-02-15 1993-02-15 Lyfjathroun H F Farmaceutisk praeparat til topisk administrering af antigener og/eller vacciner til pattedyr via slimhinder
GB9320597D0 (en) * 1993-10-06 1993-11-24 Proteus Molecular Design Improvements in and realting to vaccines
US6008228A (en) * 1995-06-06 1999-12-28 Hoffman-La Roche Inc. Pharmaceutical compositions containing proteinase inhibitors
SE9602280D0 (sv) * 1996-06-10 1996-06-10 Pharmatrix Ab Immunstimulerande lipidformulering
IS4516A (is) * 1997-07-01 1999-01-02 Gizurarson Sveinbjörn Nýtt lyfjaform
IS4518A (is) * 1997-07-09 1999-01-10 Lyfjathroun Hf, The Icelandic Bio Pharmaceutical Group Nýtt lyfjaform fyrir bóluefni
DE19756164A1 (de) * 1997-12-17 1999-06-24 Km Europa Metal Ag Verfahren zur Herstellung eines Kokillenkörpers und Kokillenkörper
FR2773489B1 (fr) * 1998-01-15 2001-03-23 Immunotech Sa Nouvelle composition destinee a la voie oromuqueuse notamment pernasale
EP1126841B1 (en) * 1998-11-02 2004-12-15 Merck & Co., Inc. Combinations of a 5ht1b/1d agonist and a selective cox-2 inhibitor for the treatment of migraine
US20030104048A1 (en) * 1999-02-26 2003-06-05 Lipocine, Inc. Pharmaceutical dosage forms for highly hydrophilic materials
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6761903B2 (en) * 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
EP1034792A1 (en) * 1999-03-11 2000-09-13 Pasteur Merieux Serums Et Vaccins Intranasal delivery of pneumococcal polysaccharide vaccines
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US6309663B1 (en) * 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
US6458383B2 (en) * 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US20030235595A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Oil-containing, orally administrable pharmaceutical composition for improved delivery of a therapeutic agent
US6468559B1 (en) * 2000-04-28 2002-10-22 Lipocine, Inc. Enteric coated formulation of bishosphonic acid compounds and associated therapeutic methods
US6495596B1 (en) * 2001-03-23 2002-12-17 Biozibe Laboratories, Inc. Compounds and methods for inhibition of phospholipase A2 and cyclooxygenase-2
WO2003016350A1 (en) * 2001-08-16 2003-02-27 Lyfjathroun H.F., Biopharmaceuticals A method of producing antibodies ex-vivo
US20030232078A1 (en) * 2001-12-19 2003-12-18 Dong Liang C. Formulation & dosage form for the controlled delivery of therapeutic agents
BR0215184A (pt) * 2001-12-20 2006-06-06 Bristol Myers Squibb Co composições farmacêuticas de derivados de taxano oralmente ativos tendo biodisponibilidade aumentada
US20050163787A1 (en) * 2002-02-25 2005-07-28 Lyfjathroun Hf, Biopharmaceutical Immunological adjuvant
NZ534738A (en) * 2002-02-25 2007-01-26 Lyfjathroun Hf Absorption enhancing agent
CA2486909A1 (en) * 2002-05-23 2003-12-04 Umd, Inc. Compositions and method for transmucosal drug delivery and cryoprotection
US6855332B2 (en) * 2002-07-03 2005-02-15 Lyfjathroun Hf. Absorption promoting agent

Also Published As

Publication number Publication date
US20050063940A1 (en) 2005-03-24
AU2003215884A1 (en) 2003-09-09
WO2003070273A1 (en) 2003-08-28
NZ534738A (en) 2007-01-26
AU2003215885B2 (en) 2008-07-03
AU2003215885A1 (en) 2003-09-09
KR20040095232A (ko) 2004-11-12
BR0307913A (pt) 2005-01-11
EP1480673A1 (en) 2004-12-01
WO2003070280A3 (en) 2004-05-13
CA2477321A1 (en) 2003-08-28
US20050106122A1 (en) 2005-05-19
CN1642576A (zh) 2005-07-20
WO2003070280A2 (en) 2003-08-28
JP2005519075A (ja) 2005-06-30
EP1521599A2 (en) 2005-04-13
IS7421A (is) 2004-08-24

Similar Documents

Publication Publication Date Title
NO20030179D0 (no) Gummimateriale
DE60308982D1 (de) Elektrolichtempfindliches Material
DE60336980D1 (de) Harzzusammensetzung
DE602004032448D1 (de) Sic-feuerfestmaterial mit daran gebundenem siliciumnitrid
DE60301389D1 (de) Verbesserter schnittstellenklebstoff
DE60336416D1 (de) Absorbierender artikel mit elastomerischen material
DE602004025653D1 (de) Photochromisches Material
DE60216331D1 (de) Flammwidrige thermoplastharzzusammensetzung
DE50305444D1 (de) Haftklebeartikel
DE602004026974D1 (de) Schichtförmiges Reibungsmaterial
DE60311192D1 (de) Bildempfangsmaterial
DE60318169D1 (de) Bahnförmiges Verbundmaterial
FR2873300B1 (fr) Materiau coupe-feu
DE602004026505D1 (de) Reibungsmaterial
ATA10012003A (de) Schichtwerkstoff
DE602004001917D1 (de) Reibungsmaterial
DE10193397T1 (de) Vulkanisierende Adhäsivzusammensetzung
IS7422A (is) Efni með viðloðunareiginleika
DK1401071T3 (da) Formstoftromle
DE60314701D1 (de) Elektrophotographisches Material
DE60331989D1 (de) Reibungsmaterial
DK1523517T3 (da) Skum med klæbemiddelmateriale-bånd
DE50202991D1 (de) Hochtemperaturfestes Klebemittel
DE112004002195D2 (de) Schmelzkleber
DE502004006220D1 (de) Gummimaterial